High Mobility Group 20B (HMG20B) (Middle Region) Peptide
HMG20B
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all HMG20B products
- HMG20B (High Mobility Group 20B (HMG20B))
- 蛋白结构域
- Middle Region
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-HMG20B antibody (Catalog #: ARP35798_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- HMG20B (High Mobility Group 20B (HMG20B))
- 背景
-
HMG20B is required for correct progression through G2 phase of the cell cycle and entry into mitosis. HMG20B is also required for RCOR1/CoREST mediated repression of neuronal specific gene promoters.
Alias Symbols: BRAF25, BRAF35, FLJ26127, HMGX2, PP7706, SMARCE1r, SOXL, pp8857, HMGXB2
Protein Interaction Partner: BRCA2,CCDC85B,HNRNPL,KIF4A,PHF21A,TACC2,VIM,BRCA2,CCDC85B,HDAC1,HDAC2,HNRNPL,KDM1A,KIF4A,PHF21A,RCOR1,SF3A2,TACC2,VIM
Protein Size: 317 - 分子量
- 37 kDa
- 基因ID
- 10362
- NCBI登录号
- NM_006339, NP_006330
- UniProt
- Q9P0W2
-
You are here:
